NCT05221320 2025-09-25
Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies
BioMed Valley Discoveries, Inc
Phase 2 Terminated
BioMed Valley Discoveries, Inc
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris